Vaxcyte Ownership 2024 | Who Owns Vaxcyte Now?
Institutional Ownership
104.48%
Insider Ownership
0.47%
Retail Ownership
-4.95%
Institutional Holders
272.00
Vaxcyte Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 13.79% | 0.08% | 16,167,340 | -93,819 | -0.58% | 1,220,795,855 | Jun 30, 2024 |
| BLACKROCK INC. | 8.48% | 0.02% | 9,939,846 | 426,839 | 4.49% | 750,557,773 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.36% | 0.01% | 9,796,995 | 59,741 | 0.61% | 739,771,093 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 7.56% | 0.36% | 8,868,907 | 1,195,039 | 15.57% | 669,721,114 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 7.00% | 8.19% | 8,203,754 | - | - | 619,465,465 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.92% | 0.06% | 4,593,066 | -326,304 | -6.63% | 346,822,414 | Jun 30, 2024 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 3.53% | 0.07% | 4,133,544 | -6,977 | -0.17% | 312,123,907 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.43% | 0.19% | 4,022,589 | 469,622 | 13.22% | 303,746,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.87% | 0.01% | 3,367,147 | 30,055 | 0.90% | 254,253,270,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.71% | 0.03% | 3,173,167 | -3,014 | -0.09% | 239,607,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.10% | 0.06% | 2,461,775 | 314,119 | 14.63% | 185,888,607 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.08% | 0.02% | 2,441,772 | 154,397 | 6.75% | 184,412,859 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 1.77% | 19.07% | 2,080,946 | -669,858 | -24.35% | 163,916,116 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.65% | 1.41% | 1,934,747 | 66,940 | 3.58% | 146,092,746 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.65% | 0.72% | 1,929,348 | 343,253 | 21.64% | 145,685,067 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.59% | 3.34% | 1,862,608 | -70,151 | -3.63% | 140,645,530 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.48% | 0.05% | 1,734,821 | -45,882 | -2.58% | 130,996,334 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 1.18% | 0.07% | 1,383,131 | 126,248 | 10.04% | 104,440,221 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 1.12% | 0.48% | 1,310,436 | -86,275 | -6.18% | 98,951,022 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.11% | 6.73% | 1,305,000 | 445,000 | 51.74% | 98,540,550 | Jun 30, 2024 |
Vaxcyte's largest institutional shareholder is FMR LLC, holding 13.79% of the company's total share outstanding, currently valued at $1.22B. The top 10 institutional shareholders own together 61.63% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 0.68% | 46.04% | 793,036 | - | - | 59,882,148 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 1.77% | 19.07% | 2,080,946 | -669,858 | -24.35% | 163,916,116 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 7.00% | 8.19% | 8,203,754 | - | - | 619,465,465 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.09% | 7.02% | 110,400 | 5,570 | 5.31% | 8,336,304 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.11% | 6.73% | 1,305,000 | 445,000 | 51.74% | 98,540,550 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.18% | 6.15% | 215,680 | 30,505 | 16.47% | 16,285,997 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.94% | 4.80% | 1,100,000 | 415,000 | 60.58% | 83,061,000 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 0.64% | 4.39% | 753,240 | 8,240 | 1.11% | 56,877,152 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 0.81% | 4.16% | 950,000 | 105,000 | 12.43% | 71,734,500 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.89% | 3.67% | 1,039,405 | -100,000 | -8.78% | 78,485,472 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.13% | 3.55% | 150,000 | 55,000 | 57.89% | 11,326,500 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.59% | 3.34% | 1,862,608 | -70,151 | -3.63% | 140,645,530 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.22% | 3.20% | 260,281 | - | - | 19,653,818 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.26% | 2.31% | 300,000 | - | - | 22,653,000 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.10% | 2.16% | 113,344 | 113,344 | 100.00% | 8,558,605 | Jun 30, 2024 |
| BRAIDWELL LP | 0.69% | 1.91% | 808,303 | -404,400 | -33.35% | 61,034,960 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.53% | 1.81% | 627,202 | -612,793 | -49.42% | 47,360,023 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.13% | 1.52% | 150,191 | 235 | 0.16% | 11,340,922 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.09% | 1.48% | 100,286 | -18,316 | -15.44% | 7,572,596 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.07% | 1.47% | 85,000 | - | - | 6,418,350 | Jun 30, 2024 |
The largest Vaxcyte shareholder by % of total assets is PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC. The company owns 793.04K shares of Vaxcyte (PCVX), representing 46.04% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.56% | 0.36% | 8,868,907 | 1,195,039 | 15.57% | 669,721,114 | Jun 30, 2024 |
| NORGES BANK | 0.84% | 0.01% | 984,464 | 984,464 | 100.00% | 74,336,877 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.43% | 0.19% | 4,022,589 | 469,622 | 13.22% | 303,746,000 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.11% | 6.73% | 1,305,000 | 445,000 | 51.74% | 98,540,550 | Jun 30, 2024 |
| BLACKROCK INC. | 8.48% | 0.02% | 9,939,846 | 426,839 | 4.49% | 750,557,773 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.36% | 0.06% | 418,715 | 418,715 | 100.00% | 31,617,170 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.94% | 4.80% | 1,100,000 | 415,000 | 60.58% | 83,061,000 | Jun 30, 2024 |
| BROWN ADVISORY INC | 0.31% | 0.04% | 367,217 | 367,217 | 100.00% | 27,728,555 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.65% | 0.72% | 1,929,348 | 343,253 | 21.64% | 145,685,067 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 0.59% | 0.99% | 687,908 | 332,777 | 93.71% | 51,943,933 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.10% | 0.06% | 2,461,775 | 314,119 | 14.63% | 185,888,607 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.60% | 0.51% | 706,903 | 313,199 | 79.55% | 53,378,246 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.29% | 0.04% | 343,552 | 296,164 | 624.98% | 25,941,643 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.25% | 0.01% | 295,762 | 187,750 | 173.82% | 22,332,991 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 0.16% | 0.01% | 186,141 | 186,141 | 100.00% | 14,055,515 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.40% | 0.00% | 471,281 | 185,405 | 64.86% | 35,586,428 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.24% | 0.01% | 277,764 | 159,231 | 134.33% | 20,973,975 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.14% | 0.01% | 159,012 | 159,012 | 100.00% | 12,007,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.08% | 0.02% | 2,441,772 | 154,397 | 6.75% | 184,412,859 | Jun 30, 2024 |
| AMUNDI | 0.38% | 0.01% | 442,308 | 139,951 | 46.29% | 33,730,408 | Jun 30, 2024 |
As of Jun 30 2024, Vaxcyte's largest institutional buyer is JANUS HENDERSON GROUP PLC. The company purchased 1.20M stocks of PCVX, valued at $669.72M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 1.77% | 19.07% | 2,080,946 | -669,858 | -24.35% | 163,916,116 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.53% | 1.81% | 627,202 | -612,793 | -49.42% | 47,360,023 | Jun 30, 2024 |
| BRAIDWELL LP | 0.69% | 1.91% | 808,303 | -404,400 | -33.35% | 61,034,960 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.45% | 0.05% | 532,904 | -328,665 | -38.15% | 40,239,581 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.92% | 0.06% | 4,593,066 | -326,304 | -6.63% | 346,822,414 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | - | - | - | -302,679 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 0.68% | 1.19% | 795,900 | -270,231 | -25.35% | 60,098,409 | Jun 30, 2024 |
| INVESCO LTD. | 0.92% | 0.02% | 1,078,720 | -155,789 | -12.62% | 81,454,147 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.21% | 0.06% | 246,242 | -138,121 | -35.94% | 18,593,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.20% | 0.02% | 230,207 | -137,042 | -37.32% | 17,382,931 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -109,389 | -100.00% | - | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.08% | 0.50% | 96,089 | -101,242 | -51.31% | 7,255,680 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.89% | 3.67% | 1,039,405 | -100,000 | -8.78% | 78,485,472 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 13.79% | 0.08% | 16,167,340 | -93,819 | -0.58% | 1,220,795,855 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.25% | 0.10% | 290,000 | -87,400 | -23.16% | 21,897,900 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 1.12% | 0.48% | 1,310,436 | -86,275 | -6.18% | 98,951,022 | Jun 30, 2024 |
| MORGAN STANLEY | 0.35% | 0.00% | 409,692 | -80,762 | -16.47% | 30,935,850 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | 0.00% | 95,676 | -80,402 | -45.66% | 7,224,495 | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -76,316 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vaxcyte's biggest institutional seller is DARWIN GLOBAL MANAGEMENT, LTD.. The company sold -0.67M shares of PCVX, valued at $163.92M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.84% | 0.01% | 984,464 | 984,464 | 100.00% | 74,336,877 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.36% | 0.06% | 418,715 | 418,715 | 100.00% | 31,617,170 | Jun 30, 2024 |
| BROWN ADVISORY INC | 0.31% | 0.04% | 367,217 | 367,217 | 100.00% | 27,728,555 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 0.16% | 0.01% | 186,141 | 186,141 | 100.00% | 14,055,515 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.14% | 0.01% | 159,012 | 159,012 | 100.00% | 12,007,000 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.10% | 2.16% | 113,344 | 113,344 | 100.00% | 8,558,605 | Jun 30, 2024 |
| WCM INVESTMENT MANAGEMENT, LLC | 0.08% | 0.02% | 92,304 | 92,304 | 100.00% | 7,270,786 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.02% | 58,737 | 58,737 | 100.00% | 4,435,231 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.01% | 57,256 | 57,256 | 100.00% | 4,335,022 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.04% | 0.32% | 41,100 | 41,100 | 100.00% | 3,103,461 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.02% | 0.00% | 23,356 | 23,356 | 100.00% | 1,763,612 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.02% | 0.03% | 22,500 | 22,500 | 100.00% | 1,698,975 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.02% | 0.35% | 19,340 | 19,340 | 100.00% | 1,460,363 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.01% | 0.13% | 15,000 | 15,000 | 100.00% | 1,132,650 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 13,946 | 13,946 | 100.00% | 1,052,696 | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 0.01% | 0.01% | 12,661 | 12,661 | 100.00% | 956,032 | Jun 30, 2024 |
| B. METZLER SEEL. SOHN & CO. AG | 0.01% | 0.01% | 10,409 | 10,409 | 100.00% | 785,984 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 36,500 | Jun 30, 2024 |
| EVERHART FINANCIAL GROUP, INC. | 0.00% | 0.11% | 5,464 | 5,464 | 100.00% | 412,587 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 0.00% | 0.00% | 4,529 | 4,529 | 100.00% | 341,985 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.00% | 0.00% | 4,404 | 4,404 | 100.00% | 332,546 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.00% | 0.15% | 3,838 | 3,838 | 100.00% | 289,807 | Jun 30, 2024 |
| CIBC ASSET MANAGEMENT INC | 0.00% | 0.00% | 3,026 | 3,026 | 100.00% | 228,493 | Jun 30, 2024 |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | 0.00% | 0.03% | 3,000 | 3,000 | 100.00% | 226,530 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.00% | 0.00% | 2,826 | 2,826 | 100.00% | 213,391 | Jun 30, 2024 |
| ENVESTNET PORTFOLIO SOLUTIONS, INC. | 0.00% | 0.00% | 2,675 | 2,675 | 100.00% | 201,989 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.00% | 0.04% | 2,500 | 2,500 | 100.00% | 188,775 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | 0.00% | 2,473 | 2,473 | 100.00% | 186,736,000 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.00% | 0.01% | 926 | 926 | 100.00% | 69,922 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.00% | 0.00% | 619 | 619 | 100.00% | 47,000 | Jun 30, 2024 |
| FIFTH THIRD BANCORP | 0.00% | 0.00% | 468 | 468 | 100.00% | 35,339 | Jun 30, 2024 |
| IFP ADVISORS, INC | 0.00% | 0.00% | 279 | 279 | 100.00% | 21,067 | Jun 30, 2024 |
| RAKUTEN SECURITIES, INC. | 0.00% | 0.01% | 258 | 258 | 100.00% | 19,482 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 180 | 180 | 100.00% | 14,178 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | 0.00% | 52 | 52 | 100.00% | 3,927 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 45 | 45 | 100.00% | 3,398 | Jun 30, 2024 |
| FINTRUST CAPITAL ADVISORS, LLC | - | 0.00% | 27 | 27 | 100.00% | 2,039 | Jun 30, 2024 |
| LYNX INVESTMENT ADVISORY | - | 0.00% | 26 | 26 | 100.00% | 1,963,000 | Jun 30, 2024 |
| AVION WEALTH | - | 0.00% | 15 | 15 | 100.00% | 1,000 | Jun 30, 2024 |
Vaxcyte's largest new institutional shareholder by number of shares is NORGES BANK, purchased 984.46K shares, valued at $74.34M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SAMLYN CAPITAL, LLC | - | - | - | -302,679 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -109,389 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -76,316 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -59,400 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -52,313 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -45,500 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -31,647 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -30,224 | -100.00% | - | Jun 30, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| HARVEST INVESTMENT SERVICES, LLC | - | - | - | -8,663 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -7,289 | -100.00% | - | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | - | - | - | -6,594 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -6,028 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -5,573 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -5,554 | -100.00% | - | Jun 30, 2024 |
| RATHBONES GROUP PLC | - | - | - | -4,330 | -100.00% | - | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | - | - | - | -3,178 | -100.00% | - | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | - | - | - | -1,184 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -800 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -547 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -57 | -100.00% | - | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
Vaxcyte's largest sold out institutional shareholder by shares sold is SAMLYN CAPITAL, LLC, sold -0.30M shares, valued at -, as of undefined.
Vaxcyte Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER INSTITUTIONAL FUNDS | 1.51% | 391,988 | -130,863 | -25.03% | Jan 31, 2024 |
| Alger ETF Trust | 1.46% | 10,371 | -693 | -6.26% | Dec 31, 2023 |
| ALGER FUNDS II | 1.38% | 311,515 | -81,271 | -20.69% | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.43% | 104,671 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.32% | 296,012 | 296,012 | - | Jan 31, 2024 |
| ALGER FUNDS | 0.31% | 295,012 | -70,815 | -19.36% | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.25% | 93,862 | -13,609 | -12.66% | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.25% | 1,230,476 | 263,482 | 27.25% | Mar 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.22% | 330,736 | 10,138 | 3.16% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.18% | 1,508,229 | -90,500 | -5.66% | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.18% | 644,733 | 152,836 | 31.07% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.17% | 354,972 | -252,430 | -41.56% | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.15% | 132,313 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.13% | 61,919 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.11% | 28,905 | 109 | 0.38% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 59,312 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.10% | 333,268 | 54,282 | 19.46% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.10% | 274,070 | -2,711 | -0.98% | Mar 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.09% | 32,000 | 32,000 | - | Mar 31, 2024 |
| NEW ECONOMY FUND | 0.09% | 396,483 | 396,483 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.08% | 215,425 | 7,425 | 3.57% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.07% | 621,939 | 93,500 | 17.69% | Jan 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.06% | 252,938 | -93,060 | -26.90% | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.06% | 1,622,742 | 123,579 | 8.24% | Feb 29, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.05% | 33,838 | -1,479 | -4.19% | Feb 29, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.05% | 110,900 | 6,300 | 6.02% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.04% | 342,695 | 342,695 | - | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.04% | 2,365,953 | - | - | Jan 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.04% | 657,970 | 657,970 | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.04% | 2,737,778 | -382,598 | -12.26% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,453,180 | 13,900 | 0.57% | Feb 29, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.04% | 412,637 | 182,231 | 79.09% | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.04% | 374,740 | 35,665 | 10.52% | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.04% | 53,324 | 3,369 | 6.74% | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 13,008 | -623 | -4.57% | Mar 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.03% | 23,688 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 186,044 | 15,243 | 8.92% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.03% | 23,350 | 23,350 | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.03% | 260,197 | 46,554 | 21.79% | Mar 28, 2024 |
| GROWTH FUND OF AMERICA | 0.03% | 703,900 | 703,900 | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 15,838 | 1,475 | 10.27% | Mar 31, 2024 |
| PIONEER SERIES TRUST II | 0.02% | 289,054 | -18,582 | -6.04% | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.02% | 14,100 | 6,900 | 95.83% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 182,704 | 4,500 | 2.53% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 233,471 | 43,200 | 22.70% | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.02% | 392,992 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 8,417,445 | -231,490 | -2.68% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 9,480 | -4,020 | -29.78% | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.02% | 614,689 | -20,277 | -3.19% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,582,451 | 183,637 | 13.13% | Jan 31, 2024 |
| HARBOR FUNDS | 0.02% | 359,101 | 51,080 | 16.58% | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 941,615 | 941,615 | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 4,318,094 | -94,222 | -2.14% | Dec 31, 2023 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.01% | 1,300 | 1,300 | - | Feb 29, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 59,075 | 59,075 | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,438 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 425,000 | 25,000 | 6.25% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 71,030 | -890 | -1.24% | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.01% | 1,530 | 1,530 | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 12,792 | 12,266 | 2331.94% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 24,793 | 403 | 1.65% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.01% | 1,428,245 | 28,900 | 2.07% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 92,830 | 78,610 | 552.81% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 21,900 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 61,584 | -12,390 | -16.75% | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 188,210 | 188,210 | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 256,299 | 594 | 0.23% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.01% | 128 | - | - | Dec 31, 2023 |
| ALPS ETF Trust | 0.01% | 70,617 | 4,323 | 6.52% | Feb 29, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.01% | 50,747 | 6,862 | 15.64% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 105,000 | 5,000 | 5.00% | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.00% | 762 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 29,890 | -70 | -0.23% | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 19,420 | -2,739 | -12.36% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 917,524 | 133,487 | 17.03% | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 175,731 | 111,202 | 172.33% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 10,545 | 1,050 | 11.06% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 7,991 | -3,933 | -32.98% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 104,710 | -42,180 | -28.72% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 23,390 | -19,509 | -45.48% | Jan 31, 2024 |
| Segall Bryant & Hamill Trust | 0.00% | 54,083 | 715 | 1.34% | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 28,780 | 6,344 | 28.28% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 13,310 | - | - | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 59,761 | 1,500 | 2.57% | Mar 31, 2024 |
| FORUM FUNDS | 0.00% | 4,280 | - | - | Jan 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 8,499 | -1,082 | -11.29% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 22,296 | - | - | Jan 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 100,100 | -4,665 | -4.45% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2,076 | -337 | -13.97% | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.00% | 3,703 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 327,767 | 71,231 | 27.77% | Feb 29, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 3,200 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 128,971 | 37,774 | 41.42% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 27,144 | 3,685 | 15.71% | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 8,778 | -2,468 | -21.95% | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,568 | 1,027 | 22.62% | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 44,699 | -3,631 | -7.51% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 34,369 | -3,162 | -8.43% | Mar 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 248,724 | 248,724 | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 30,437 | 6,295 | 26.07% | Mar 28, 2024 |
Vaxcyte's largest mutual fund holder by % of total assets is "ALGER INSTITUTIONAL FUNDS", owning 391.99K shares, compromising 1.51% of its total assets.
Vaxcyte Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 272 | 4.21% |
| 31 Mar, 24 | 261 | 14.47% |
| 31 Dec, 23 | 228 | 11.22% |
| 30 Sep, 23 | 205 | -0.97% |
| 30 Jun, 23 | 207 | 7.81% |
| 31 Mar, 23 | 192 | -10.28% |
| 31 Dec, 22 | 214 | 64.62% |
| 30 Sep, 22 | 130 | 22.64% |
| 30 Jun, 22 | 106 | 20.45% |
| 31 Mar, 22 | 88 | 2.33% |
| 31 Dec, 21 | 86 | 8.86% |
| 30 Sep, 21 | 79 | 6.76% |
| 30 Jun, 21 | 74 | -2.63% |
| 31 Mar, 21 | 76 | -6.17% |
| 31 Dec, 20 | 81 | 37.29% |
| 30 Sep, 20 | 59 | 55.26% |
| 30 Jun, 20 | 38 | - |
As of 30 Jun 24, 272 institutions are holding Vaxcyte's shares, representing an increase of 4.21% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 122,504,450 | 3.80% |
| 31 Mar, 24 | 118,023,704 | 14.54% |
| 31 Dec, 23 | 103,039,966 | 2.47% |
| 30 Sep, 23 | 100,552,533 | 0.28% |
| 30 Jun, 23 | 100,269,608 | 19.24% |
| 31 Mar, 23 | 84,089,973 | 3.13% |
| 31 Dec, 22 | 81,538,115 | 44.39% |
| 30 Sep, 22 | 56,469,250 | 9.82% |
| 30 Jun, 22 | 51,418,534 | 3.17% |
| 31 Mar, 22 | 49,840,314 | 11.49% |
| 31 Dec, 21 | 44,705,488 | 3.52% |
| 30 Sep, 21 | 43,184,123 | -0.06% |
| 30 Jun, 21 | 43,208,423 | -1.85% |
| 31 Mar, 21 | 44,020,835 | 4.22% |
| 31 Dec, 20 | 42,238,911 | 11.88% |
| 30 Sep, 20 | 37,752,278 | 5.01% |
| 30 Jun, 20 | 35,950,832 | - |
Vaxcyte (PCVX) has 122.50M shares outstanding as of 30 Jun 24, up 3.80% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 104.48% | 0.94% |
| 31 Mar, 24 | 105.67% | 0.94% |
| 31 Dec, 23 | 106.05% | 1.08% |
| 30 Sep, 23 | 98.90% | 0.95% |
| 30 Jun, 23 | 102.26% | 1.07% |
| 31 Mar, 23 | 97.54% | 0.62% |
| 31 Dec, 22 | 125.68% | 1.51% |
| 30 Sep, 22 | 91.10% | 1.27% |
| 30 Jun, 22 | 84.54% | 1.13% |
| 31 Mar, 22 | 86.61% | 1.18% |
| 31 Dec, 21 | 85.66% | 1.25% |
| 30 Sep, 21 | 82.75% | 1.18% |
| 30 Jun, 21 | 83.89% | 1.13% |
| 31 Mar, 21 | 86.02% | 1.25% |
| 31 Dec, 20 | 82.88% | 1.51% |
| 30 Sep, 20 | 74.18% | 1.25% |
| 30 Jun, 20 | 76.89% | - |
As of 30 Jun 24, Vaxcyte is held by 104.48% institutional shareholders, representing a 0.94% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 158 | 6.76% |
| 31 Mar, 24 | 148 | 18.40% |
| 31 Dec, 23 | 125 | 13.64% |
| 30 Sep, 23 | 110 | -24.14% |
| 30 Jun, 23 | 145 | 59.34% |
| 31 Mar, 23 | 91 | -47.70% |
| 31 Dec, 22 | 174 | 128.95% |
| 30 Sep, 22 | 76 | 5.56% |
| 30 Jun, 22 | 72 | 50.00% |
| 31 Mar, 22 | 48 | 4.35% |
| 31 Dec, 21 | 46 | 24.32% |
| 30 Sep, 21 | 37 | -19.57% |
| 30 Jun, 21 | 46 | -8.00% |
| 31 Mar, 21 | 50 | -9.09% |
| 31 Dec, 20 | 55 | 37.50% |
| 30 Sep, 20 | 40 | 5.26% |
| 30 Jun, 20 | 38 | - |
158 institutional shareholders have increased their position in PCVX stock as of 30 Jun 24 compared to 148 in the previous quarter (a 6.76% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 73 | -7.59% |
| 31 Mar, 24 | 79 | 16.18% |
| 31 Dec, 23 | 68 | 17.24% |
| 30 Sep, 23 | 58 | 48.72% |
| 30 Jun, 23 | 39 | -36.07% |
| 31 Mar, 23 | 61 | 177.27% |
| 31 Dec, 22 | 22 | -15.38% |
| 30 Sep, 22 | 26 | 44.44% |
| 30 Jun, 22 | 18 | -14.29% |
| 31 Mar, 22 | 21 | -4.55% |
| 31 Dec, 21 | 22 | -12.00% |
| 30 Sep, 21 | 25 | 56.25% |
| 30 Jun, 21 | 16 | 23.08% |
| 31 Mar, 21 | 13 | - |
| 31 Dec, 20 | 13 | 18.18% |
| 30 Sep, 20 | 11 | - |
| 30 Jun, 20 | - | - |
73 institutional shareholders have reduced their position in PCVX stock as of 30 Jun 24 compared to 79 in the previous quarter (a -7.59% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 272 | 4.21% | 122,504,450 | 3.80% | 104.48% | 0.94% | 158 | 6.76% | 73 | -7.59% |
| 31 Mar, 24 | 261 | 14.47% | 118,023,704 | 14.54% | 105.67% | 0.94% | 148 | 18.40% | 79 | 16.18% |
| 31 Dec, 23 | 228 | 11.22% | 103,039,966 | 2.47% | 106.05% | 1.08% | 125 | 13.64% | 68 | 17.24% |
| 30 Sep, 23 | 205 | -0.97% | 100,552,533 | 0.28% | 98.90% | 0.95% | 110 | -24.14% | 58 | 48.72% |
| 30 Jun, 23 | 207 | 7.81% | 100,269,608 | 19.24% | 102.26% | 1.07% | 145 | 59.34% | 39 | -36.07% |
| 31 Mar, 23 | 192 | -10.28% | 84,089,973 | 3.13% | 97.54% | 0.62% | 91 | -47.70% | 61 | 177.27% |
| 31 Dec, 22 | 214 | 64.62% | 81,538,115 | 44.39% | 125.68% | 1.51% | 174 | 128.95% | 22 | -15.38% |
| 30 Sep, 22 | 130 | 22.64% | 56,469,250 | 9.82% | 91.10% | 1.27% | 76 | 5.56% | 26 | 44.44% |
| 30 Jun, 22 | 106 | 20.45% | 51,418,534 | 3.17% | 84.54% | 1.13% | 72 | 50.00% | 18 | -14.29% |
| 31 Mar, 22 | 88 | 2.33% | 49,840,314 | 11.49% | 86.61% | 1.18% | 48 | 4.35% | 21 | -4.55% |
| 31 Dec, 21 | 86 | 8.86% | 44,705,488 | 3.52% | 85.66% | 1.25% | 46 | 24.32% | 22 | -12.00% |
| 30 Sep, 21 | 79 | 6.76% | 43,184,123 | -0.06% | 82.75% | 1.18% | 37 | -19.57% | 25 | 56.25% |
| 30 Jun, 21 | 74 | -2.63% | 43,208,423 | -1.85% | 83.89% | 1.13% | 46 | -8.00% | 16 | 23.08% |
| 31 Mar, 21 | 76 | -6.17% | 44,020,835 | 4.22% | 86.02% | 1.25% | 50 | -9.09% | 13 | - |
| 31 Dec, 20 | 81 | 37.29% | 42,238,911 | 11.88% | 82.88% | 1.51% | 55 | 37.50% | 13 | 18.18% |
| 30 Sep, 20 | 59 | 55.26% | 37,752,278 | 5.01% | 74.18% | 1.25% | 40 | 5.26% | 11 | - |
| 30 Jun, 20 | 38 | - | 35,950,832 | - | 76.89% | - | 38 | - | - | - |
Vaxcyte Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vaxcyte's stock was made by Wassil Jim on Aug 05 2024, selling 2,977 shares at $78.84 per share (valued at $234.70K).
Vaxcyte Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 6 | 23 | 26.09% |
| Q2 2024 | 26 | 57 | 45.61% |
| Q1 2024 | 32 | 95 | 33.68% |
| Q4 2023 | 19 | 53 | 35.85% |
| Q3 2023 | 2 | 12 | 16.67% |
| Q2 2023 | 14 | 1 | 1400.00% |
| Q1 2023 | 10 | 9 | 111.11% |
| Q4 2022 | 17 | 17 | 100.00% |
| Q3 2022 | 10 | 55 | 18.18% |
| Q2 2022 | 21 | 26 | 80.77% |
| Q1 2022 | 22 | 15 | 146.67% |
| Q4 2021 | 14 | 28 | 50.00% |
| Q3 2021 | 12 | 27 | 44.44% |
| Q2 2021 | 18 | 32 | 56.25% |
| Q1 2021 | 14 | 78 | 17.95% |
| Q4 2020 | 4 | 11 | 36.36% |
| Q3 2020 | - | 2 | - |
| Q2 2020 | 21 | 42 | 50.00% |
6 total buy trades, and 23 total sell trades (buy/sell ratio of 0.26%) were made by Vaxcyte's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 17 | - |
| Q2 2024 | - | 46 | - |
| Q1 2024 | - | 70 | - |
| Q4 2023 | - | 37 | - |
| Q3 2023 | - | 5 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 2 | - |
| Q4 2022 | - | 9 | - |
| Q3 2022 | - | 33 | - |
| Q2 2022 | - | 17 | - |
| Q1 2022 | - | 9 | - |
| Q4 2021 | - | 14 | - |
| Q3 2021 | - | 15 | - |
| Q2 2021 | - | 11 | - |
| Q1 2021 | - | 64 | - |
| Q4 2020 | - | 8 | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | 4 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 17 open market sell trades of Vaxcyte's stocks.
Vaxcyte Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| IMCR | Immunocore Holdings plc |
| BMRN | BioMarin Pharmaceutical Inc. |
| TVTX | Travere Therapeutics, Inc. |
| STRO | Sutro Biopharma, Inc. |
| LEGN | Legend Biotech Corporation |
| SNDX | Syndax Pharmaceuticals, Inc. |
| ACLX | Arcellx, Inc. |
| LQDA | Liquidia Corporation |
| TECH | Bio-Techne Corporation |
PCVX Ownership FAQ
Who Owns Vaxcyte?
Vaxcyte is owned by institutional shareholders (104.48%), insiders (0.47%), and public (-4.95%). The largest institutional shareholder of Vaxcyte is FMR LLC (13.79% of total shares) and the top mutual fund owner is ALGER INSTITUTIONAL FUNDS (1.51% of total shares).
Who are the major institutional shareholders of Vaxcyte?
Vaxcyte's major institutional shareholders are FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, and RA CAPITAL MANAGEMENT, L.P.. The top five shareholders own together 45.18% of the company's share outstanding.
How many Vaxcyte shareholders are there?
As of Jun 2024, there are 272 institutional shareholders of Vaxcyte.
What percentage of Vaxcyte is owned by FMR LLC?
FMR LLC owns 16.17M shares of Vaxcyte, representing 13.79% of the company's total shares outstanding, valued at $1.22B (as of Jun 2024).
What percentage of Vaxcyte is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 9.94M shares of Vaxcyte (PCVX), compromising 8.48% of the company, valued at $750.56M.
What percentage of Vaxcyte is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Vaxcyte. The company owns 9.8M of the company's shares outstanding (worth $739.77M).